Blog - Metastatic Breast Cancer Trial Talk

Archives

FDA Approves Itovebi

On October 10, 2024, the FDA approved inavolisib (ItovebiTM, Genentech, Inc.) with palbociclib (Ibrance®) and fulvestrant (Faslodex®) and a companion diagnostic...
Read More

SEARCH OUR SITE

for past articles or specific information.